Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Ates cash on hand is dropping 8-12 mill a quarter
View:
Post by Stutters on Jan 11, 2022 4:41pm

Ates cash on hand is dropping 8-12 mill a quarter

then they will have to raise money
Comment by MrMugsy on Jan 11, 2022 7:50pm
I estimate it will work out to a spend of $2.5M per month. Add something back for the sale of CITA - let's call it $7.5M (for now). That would get us well into 2024 so they likely wouldn't be contemplating going to markets until Q3-Q4 of 2024 - world away. Question is ... are they willing to up the development work at Dalriada or are they planning on going slowly ?  I'm betting ...more  
Comment by StockingUp21 on Jan 11, 2022 9:40pm
They will not wait until bank account is empty to raise money. You know I know muggy knows too. He is a wolf in sheep clothing. Beware!
Comment by MrMugsy on Jan 11, 2022 10:24pm
Oooooooooo .. a wolf in sheeps clothing ... makes me sound mysterious. Very cool. Makes you sound a lot paranoid. Don't fear the wind Stocky - it can't really hurt you. : )
Comment by StockingUp21 on Jan 12, 2022 10:59am
This post has been removed in accordance with Community Policy
Comment by TheMadMonk on Jan 11, 2022 9:49pm
Don't forget that there are approximately 8 million warrants outstanding that expire between February 2022 and February 2024.  If all 8 million warrants expire that means that the company can sell an additional 8 million shares without diluting shareholders any further.  After P3 starts there is a reasonable chance that the stock would be valued above $5 per share.  If that is ...more  
Comment by woundedknee on Jan 13, 2022 8:51am
MadMonk...you stated in your post that after P3 starts this may ne valued above 5 dollars. Your name fits you perfectly. lol
Comment by TheMadMonk on Jan 13, 2022 11:44am
Hey Wounded, I'll have you know that my team of psychiatrists say that I am doing much better now.  I was being conservative on my $5 price target.  Provided that everything goes well with P2 and we as we start P3, I think that there will be excitement around this company again and the stock price will reflect that.  These shares were trading over $7 heading into an AME ...more  
Comment by woundedknee on Jan 14, 2022 3:13pm
MadMonk...nice to see you have a sense of humor. I like your optimism as well and I hope you are right. Have a good weekend.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities